2603 Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs). (September 2015) - Santini, D.; Santoni, M.; Conti, A.; Procopio, G.; Verzoni, E.; Galli, L.; Di Lorenzo, G.; De Giorgi, U.; De Lisi, D.; Nicodemo, M.; Maruzzo, M.; Massari, F.; et al.